BioLine RX (Israel) Technical Analysis
| BLRX Stock | ILS 1.50 0.10 6.25% |
As of the 30th of January, BioLine RX shows the Standard Deviation of 4.55, risk adjusted performance of (0.06), and Mean Deviation of 3.24. BioLine RX technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioLine RX Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioLine, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioLineBioLine |
BioLine RX 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLine RX's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLine RX.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in BioLine RX on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding BioLine RX or generate 0.0% return on investment in BioLine RX over 90 days. BioLine RX is related to or competes with Can Fite, Clal Biotechnology, Evogene, XTL Biopharmaceutica, Together Startup, Enlivex Therapeutics, and BioLight Life. BioLineRx Ltd., a clinical stage biopharmaceutical development company, focuses on oncology and immunology More
BioLine RX Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLine RX's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLine RX upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 18.01 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.67 |
BioLine RX Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLine RX's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLine RX's standard deviation. In reality, there are many statistical measures that can use BioLine RX historical prices to predict the future BioLine RX's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | 3.76 |
BioLine RX January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 3.77 | |||
| Mean Deviation | 3.24 | |||
| Coefficient Of Variation | (1,080) | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.7 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | 3.76 | |||
| Maximum Drawdown | 18.01 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.67 | |||
| Skewness | 0.669 | |||
| Kurtosis | 0.1904 |
BioLine RX Backtested Returns
BioLine RX secures Sharpe Ratio (or Efficiency) of -0.0926, which signifies that the company had a -0.0926 % return per unit of risk over the last 3 months. BioLine RX exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLine RX's Standard Deviation of 4.55, risk adjusted performance of (0.06), and Mean Deviation of 3.24 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioLine RX are expected to decrease at a much lower rate. During the bear market, BioLine RX is likely to outperform the market. At this point, BioLine RX has a negative expected return of -0.42%. Please make sure to confirm BioLine RX's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if BioLine RX performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.52 |
Modest predictability
BioLine RX has modest predictability. Overlapping area represents the amount of predictability between BioLine RX time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLine RX price movement. The serial correlation of 0.52 indicates that about 52.0% of current BioLine RX price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
BioLine RX technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioLine RX Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioLine RX volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About BioLine RX Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioLine RX on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioLine RX based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioLine RX price pattern first instead of the macroeconomic environment surrounding BioLine RX. By analyzing BioLine RX's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioLine RX's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioLine RX specific price patterns or momentum indicators. Please read more on our technical analysis page.
BioLine RX January 30, 2026 Technical Indicators
Most technical analysis of BioLine help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioLine from various momentum indicators to cycle indicators. When you analyze BioLine charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 3.77 | |||
| Mean Deviation | 3.24 | |||
| Coefficient Of Variation | (1,080) | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.7 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | 3.76 | |||
| Maximum Drawdown | 18.01 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.67 | |||
| Skewness | 0.669 | |||
| Kurtosis | 0.1904 |
BioLine RX January 30, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioLine stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | (1.00) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 1.55 | ||
| Day Typical Price | 1.53 | ||
| Price Action Indicator | (0.10) | ||
| Market Facilitation Index | 0.10 |
Complementary Tools for BioLine Stock analysis
When running BioLine RX's price analysis, check to measure BioLine RX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLine RX is operating at the current time. Most of BioLine RX's value examination focuses on studying past and present price action to predict the probability of BioLine RX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLine RX's price. Additionally, you may evaluate how the addition of BioLine RX to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets |